Verena Weber
BA in Business Administration, Intercultural Qualification, University of Mannheim.

"The Chair seminars gave me a broad yet precise vision of the challenges faced by the biopharmaceutical industry while raising deep and original ethical questions. Through lively, invigorating debates with the lecturers, the Chair classes were among the most exciting of the whole MBA program. This training is a precious asset to guide my career in the drug industry or in an international organization tied to the health sector."

Harald van Aubel
MSc International Economics and Business, Rotterdam School of Economics.

"As a student from the Rotterdam School of Economics, I was surprised by the originality and interactivity of the ESSEC-sanofi-aventis Chair courses. The visits of sites and the guest lecturers made the seminars both lively and stimulating. If you are interested in a career in the biopharmaceutical industry, this course is a must!"

Anne Sophie Souhaité
Ecole Normale Supérieure (Ulm), Institut d'Etudes Politiques de Paris.

"After studying German and Philosophy at the Ecole Normale Supérieure and then graduating from the Institut d'Etudes Politiques de Paris, I was admitted to ESSEC and then the Chair in 2005. The international approach and high ideals found in its seminars helped me to rethink the connection between humanistic values and economic stakes. This Chair opens up the professional horizons I aspire to, namely working for an international organization such as the World Health Organization, the High Commission for Human Rights, or positions involving regulatory affairs in the pharmaceutical industry."

Baolei Han
Bachelor in Medicine, major in Health administration, Beijing University.

"After my medical studies at the University of Beijing and several experiences in the Asian pharmaceutical industry, I came to ESSEC and the Chair. The tremendous richness of the seminars is mainly due to the wide variety of lecturers and the quality of the debates between participants. They showed me a radically new view of drugs and the health industry."

Aurélia Schmidt
Docteur en Pharmacie, Université Paris XI.

"After my PhD in pharmacology, followed by a professional experience in pharmaceutical marketing and financial analysis, I felt a deepseated need to take the time to test my viewpoint with people in the sector that have questions on ethical issues, which are often oversimplified. The Chair gave me the opportunity for numerous discussions with students and fascinating lecturers. They enlightened me on the future of the industry and the issues at stake. Most importantly, they strengthened my motivation. Working in this sector today - as a junior product manager - is incredibly exciting."

Xueying Feng
BA in Economics and Foreign Languages, University of Canton.

"In my discussions with other students at the Chair, I was able to really discover the European value system on major social issues relating to the biopharmaceutical industry. Our exchanges on human rights, human cloning and the precautionary principle were especially enriching. Cultivating this different, critical approach will be a precious asset for my future career in the health industry."

Sarah McKee
Classes préparatoires, ESSEC MBA.

"I took the seminar Ethical Dilemmas in the Biopharmaceutical Industry. I found it to be the most thought-provoking class at ESSEC. By broaching the issue of ethics in the drug industry, this class allowed me to acquire a great deal of maturity and a more discriminating approach in my professional life. Managers of my generation are no longer willing to work for just any industry: we expect our company to behave ethically. The creation of the ESSEC-sanofi-aventis Chair shows that our school takes the ethical concerns of its students very seriously. I'm very proud of that."